Biomet CEO Jeffrey Binder defends medical devices against reports that paint technology as a significant contributor to the ever-rising cost of U.S. healthcare.
MASSDEVICE ON CALL — Recent data exposures from the Centers for Medicare & Medicaid have raised eyebrows about the cost of U.S. healthcare and variability among care providers, but Biomet CEO Jeffrey Binder insists that medical devices are not to blame.
In a new editorial written for Philly.com, Binder defended the industry and its role in the ever-rising cost of U.S. healthcare, writing that medtech more often helps curb costs by keeping people healthier longer and out of the hospital.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/RTSN4y
Cap comentari:
Publica un comentari a l'entrada